Navigation Links
University of Pennsylvania and Novartis Form Alliance to Expand Use of Personalized T Cell Therapy for Cancer Patients
Date:8/5/2012

PHILADELPHIA, Aug. 6, 2012 /PRNewswire-USNewswire/ -- In an alliance aimed at bringing a new, personalized immunotherapy approach to patients with a wide variety of cancers, the University of Pennsylvania and Novartis announced today an exclusive global research and licensing agreement to further study and commercialize novel cellular immunotherapies using chimeric antigen receptor (CAR) technologies. The agreement, which follows a Penn research team's 2011 publication of breakthrough results in several chronic lymphocytic leukemia patients treated with this personalized immunotherapy technique, paves the way for pivotal studies that have the potential to expand the use of CAR therapies for additional cancers.

The new alliance represents a marquee achievement in Penn's commitment to translational science aimed at expediting the process of bringing novel therapies to patients. Together, Penn and Novartis will build a first-of-its-kind Center for Advanced Cellular Therapies (CACT) on the Penn campus in Philadelphia -- a venture which will bring full circle the 1960 discovery of the Philadelphia chromosome, the first description of a chromosome abnormality that causes cancer. The center will be devoted to the discovery, development and manufacturing of adoptive T cell immunotherapies through a joint research and development program led by scientists and clinicians from Penn, Novartis, and the Novartis Institutes for Biomedical Research.

"Penn's intellectual resources, combined with a pharmaceutical industry leader like Novartis, offer a powerful symbiotic relationship in our mutual goal of finding more effective treatments for cancer," said J. Larry Jameson, MD, PhD, dean of the Perelman School of the Medicine at the University of Pennsylvania and executive vice president for the Health System. "With our shared commitment to rapidly advancing new therapies and cures,
'/>"/>

SOURCE University of Pennsylvania
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
2. University Hospitals Case Medical Centers Harrington Discovery Institute Launches Grant Program to Accelerate Drug Discovery and Development
3. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
4. Guangzhous Sun Yat-sen University Cancer Center Debuts MOSAIQ in the Chinese Platform
5. Pharmaceutics International, Inc. (Pii) Supports University Pharmaceutical Technology Education and Research
6. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
7. Sensus Healthcare and Texas Dermatology Associates at Baylor University Medical Center Announce the Formation of the SRT University™ Comprehensive Education Series for Practitioners, Healthcare Professionals, and Patients
8. Student of Liver And Vascular Surgery of West China Hospital of Sichuan University Addresses The 18th ILTS Annual Meeting in the United States
9. University of Michigans Wolverine Venture Fund Participates in $25 Million Series D Investment in Sonitus Medical
10. Oregon State University Launches New Online Learning System For Pharmacy Managers
11. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Ill. , May 5, 2015 ... diagnostic testing equipment and information systems technology, today ... information systems company. This partnership allows Sysmex and ... and interfacing solution for physician offices and clinics ... directly to Electronic Medical Record (EMR) systems. ...
(Date:5/5/2015)... -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, ... on discovering, developing and commercializing novel therapeutics from ... closing of the previously announced offering on the ... Depositary Shares (ADSs) at a price of $112.00 ... million (before deducting underwriting discount, commissions and offering ...
(Date:5/5/2015)... YORK , May 5, 2015  IBM Watson ... is collaborating with more than a dozen leading cancer ... and personalize treatment options for their patients. The institutes ... capabilities to reduce from weeks to minutes the ability ... and gather relevant information from medical literature to personalize ...
Breaking Medicine Technology:Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6
(Date:5/6/2015)... 2015 Healthcare marketing agency Smith ... silver award in the 2015 Aster Awards for its ... Ellis Medicine’s maternity campaign, respectively. The Aster Awards recognize ... and marketing agencies. , The branding campaign for ... — other/misc. category and hospital 150-200 bed group. The ...
(Date:5/6/2015)... 06, 2015 The SGNY Group LLC ... City, announced today that it was named a Platinum ... presentation video produced on behalf of Intarcia Therapeutics. ... of motion graphics. , The competition sponsored by the ... 6000 entries from 22 countries. The competition is ...
(Date:5/6/2015)... May 06, 2015 The beverage industry ... drinks. Little Miracles organic tea and superfruit fusions stands ... ginseng and sweetened with agave, these delicious juice blends ... that seeks healthier ways to hydrate. , In collaboration ... invites people to raise a bottle of Lemongrass Tea ...
(Date:5/5/2015)... 05, 2015 With the FCPX LUT: Monochromatic ... and easily add washed color grades to footage. A LUT ... modifying an image. The LUT changes every pixel's color to ... with 90 washed CUBE LUT files. , This plugin was ... give any footage a washed look. , CUBE LUT ...
(Date:5/5/2015)... Hills Cosmetic Dentist, Arthur Glosman released a luxury line of ... the offices of Arthur Glosman DDS, 450 N Roxbury Drive ... online store . “I wanted to be one of the ... beauty with a luxurious collection of products designed to make ... Dr. Glosman’s Advanced Dental Health + Beauty™ products use a ...
Breaking Medicine News(10 mins):Health News:Smith & Jones Wins in 2015 Aster Awards for Healthcare Marketing 2Health News:The SGNY Group Wins Platinum Hermes Creative Award 2Health News:Say Cheers to National Beverage Day with Little Miracles 2Health News:Pixel Film Studios Announced the Release of FCPX LUT Monochromatic 2Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2
... which is a serious problem in people with cancer, AIDS ... lungs and heart. A recent study has found that the ... flies, where it is involved in muscle development, could help ... have been studying the function of the twist gene in ...
... in Chapel Hill that was published in the Jan. 15 ... - C282Y and H63D, which are linked to the iron ... of developing colon cancer. For the research, the genes of ... than 400 already had colon cancer, and were matched with ...
... Researchers from the department of urology in a ... response to hormone-refractory prostate cancer could be measured ... prostate cancer doubling time may be an auxiliary ... hormone refractory prostate cancer. ,The study was ...
... psychologists at the Tufts University in Boston has revealed that ... emotions displayed on television. They also use emotional information picked ... Mumme, assistant professor of psychology at Tufts University, and her ... objects such as a red spiral letter holder, a blue ...
... outlines a new method developed by Microbia Ltd.'s ... production of industrial molecules produced in microbes. This ... improve the properties// of microbial cells for biomanufacturing ... the illumination of the best route to optimize ...
... by researchers at Pace University in New York found from ... 1993 until 1999 found that the percentage of women who ... more than half of those were unable to remain ex-smokers ... the American Journal of Preventive Medicine suggested that the results ...
Cached Medicine News:
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: